Brooks Laboratories Limited has submitted to the Exchange, the financial results for the year ended March 31, 2025.
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Brooks Laboratories Limited has submitted its financial results for the financial year ended March 31, 2025 to the National Stock Exchange. This is a routine regulatory filing required under SEBI listing obligations for listed companies. The announcement does not include detailed financial figures such as revenue, profit after tax, or margins. Shareholders and investors would need to refer to the detailed results document to assess the company's actual financial performance for FY25.
This is a standard compliance submission and does not by itself indicate any positive or negative development. Investors should look at the detailed financial results to evaluate the company's actual performance and any impact on the stock price.